Brief: Jacobson Pharma's Unit Launched A Home Diagnostic Product In Hong Kong & Macau
05/02/2020 09:44
Feb 5 (Reuters) - Jacobson Pharma Corporation Ltd 2633.HK :
* UNIT LAUNCHED HOME DIAGNOSTIC PRODUCT FOR INFLUENZA &
RESPIRATORY SYNCYTIAL VIRUS IN MARKETS OF HONG KONG & MACAU
* HOME DIAGNOSTIC PRODUCT UNDER BRAND NAME OF "DR. FREEMAN
FLU/RSV
COMBO"
* IN DISCUSSION WITH OVERSEAS SUPPLIERS FOR OTHER DIAGNOSTIC
PRODUCTS TO BE LAUNCHED UNDER BRAND NAME OF DR. FREEMAN
Source text for Eikon: ID:nHKS1zryss
Further company coverage: 2633.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jacobson Pharma
See all newsBrief: Jacobson Pharma Corp Says Chai Herbal To Buy 124,500 Shares Of Li Chung Shing Tong (Holdings)
Brief: Jacobson Pharma Corp's Unit Accepts Tender For Tai Po Factory Works At Hk$607.2 Million
Brief: Jacobson Pharma Corp Posts H1 Revenue Of HKD 766.6 Million
Brief: Jacobson Pharma Corporation Posts FY Net Income Attributable HKD 300.8 Million
Brief: Jacobson Pharma Corporation To Subscribe Shares In Tycoon Group